Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Apo-Solifenacin
Solifenacin succinate 5mg
Film coated tablet
Apotex NZ Limited
Apotex Research Private Limited, Bangalore, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Apo-Solifenacin
Solifenacin succinate 10mg
Film coated tablet
Apotex NZ Limited
Apotex Research Private Limited, Bangalore, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Fexofenadine Hayfever & Allergy Relief
Fexofenadine hydrochloride 180mg
Film coated tablet
PSM Healthcare Limited trading as API Consumer Brands
Medreich Limited, Bangalore, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Maltofer Syrup
Iron polymaltose 37mg/mL equivalent to iron 10mg/mL
Syrup
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Vifor SA, Villars-sur-Glane, Switzerland
Iberfar - Industria Farmaceutica S.A., Barcarena, Portugal
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Maltofer Tablets
Iron polymaltose 370mg equivalent to iron 100mg
Film coated tablet
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Vifor SA, Villars-sur-Glane, Switzerland
|
Dated this 5th day of June 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz